1. Introduction {#sec0005}
===============

Monepantel (Zolvix^®^) was first registered for use in sheep in 2009 and 2010 in New Zealand and Australia, respectively ([@bib0050]) and subsequently registered for use in other significant sheep producing regions, including the UK. The product was launched in response to the growing threat, and increasing prevalence, of resistance to the three broad-spectrum anthelmintic groups available at the time ([@bib0055]). Marketing of the product in the UK was accompanied by practical advice on its responsible use to attempt to delay the onset of anthelmintic resistance. The product was recommended, in the UK, for administration during quarantine of introduced animals ([@bib0080]) and/or as a mid/late season drench ([@bib0060]). Unfortunately, resistance to monepantel was reported within a few years of release in New Zealand, Australia, Uruguay, Brazil and the Netherlands ([@bib0015], [@bib0070], [@bib0075], [@bib0085], [@bib0095]). Monepantel resistance was first reported in the UK in 2018 ([@bib0040]) with *Trichostrongylus vitrinus* being the predominant resistant parasite species, as determined by ITS-2 deep amplicon sequence analysis of post treatment coprocultured L~3~. The methods showed the presence/absence of species pre and post monepantel administration ([@bib0040]), but did not provide any information on anthelmintic efficacy at a species level. This study provides the individual species sensitivities to monepantel through characterisation of the field population from the same index case.

2. Materials and methods {#sec0010}
========================

2.1. Parasite isolates {#sec0015}
----------------------

Faecal material was collected from lambs from the farm of interest that had been identified through ongoing animal health management ([@bib0040]) and cultured to generate infective larvae (L~3~). Larvae were stored in tap water at 4 °C for seven weeks prior to use in the study.

2.2. Experimental design {#sec0020}
------------------------

Twelve worm free lambs were challenged *per os* with 15,000 infective larvae (Day 0). Twenty eight days post infection (PI) monepantel (Zolvix^®^, Elanco AH) was administered *per os* at the manufacturer's recommended dose rate of 2.5 mg/kg bodyweight (BW) to six lambs. All anthelmintic treatment doses were rounded up to the nearest 1 ml (dosage range 2.58--3.09 mg/kg BW). Six lambs were left untreated to act as a control group and to confirm the viability of the infective larvae. Faecal egg counts were monitored on individual faecal samples throughout the trial from day 12 post infection. A modification of the salt flotation faecal egg count method as detailed by [@bib0010] was used, the technique has a sensitivity of up to one egg per gram. All of the lambs were slaughtered on day 35 PI and their gastrointestinal tracts removed and processed for worm burden estimation. Total nematode burdens were estimated from counts of 2% sub-samples of the abomasal and intestinal washings and saline digests. Enumerated nematodes were classified to stage and species using criteria described in the Ministry of Agriculture, Fisheries and Food document ([@bib0065]).

2.3. Statistical analysis {#sec0025}
-------------------------

Nematode burdens and FECs were square-root transformed to successfully normalise for variance. Burdens were compared using one way ANOVA (Minitab version 13), followed by Fisher's pairwise comparisons when found to be significant at P \< 0.05. The percentage efficacy (PE) of each treatment was calculated by means of the standard equation: (1-(T/C)) X 100 where C and T are the arithmetic mean total nematode burdens or FECs (on day 35 PI) of the untreated control and treated groups, respectively ([@bib0025]). Anthelmintic resistance was deemed to be present when the PE in reducing FEC was \<95%, with a lower 95% confidence limit of \<90%.

All experimental procedures described here were approved by the Moredun Research Institute Experiments and Ethics Committee and were conducted under the legislation of a UK Home Office License (reference P95890EC1) in accordance with the Animals (Scientific Procedures) Act of 1986.

3. Results {#sec0030}
==========

3.1. Faecal egg counts {#sec0035}
----------------------

Faecal egg counts rose in all of the animals from day 14 post infection until day 28 PI, peaking at an arithmetic mean of 364 eggs per gram (range 24--1044). The arithmetic mean FECs of the treatment group fell following monepantel administration on day 28 PI, but rebounded thereafter ([Fig. 1](#fig0005){ref-type="fig"}). FECs plateaued in the untreated control group. Efficacy based on undifferentiated FEC was 85% (95% CI 61% 94%) on day seven post monepantel administration. A significant difference (p = 0.04) in FEC compared to non-treated control animals at day seven post treatment was observed.Fig. 1Faecal egg counts (±standard error of the mean) of lambs artificially infected with 15,000 infective larvae of field derived isolate. Lambs were either administered monepantel (dashed line) on day 28 post infection or left untreated (solid line) as controls.Fig. 1

3.2. Nematode burden analysis {#sec0040}
-----------------------------

The arithmetic mean percentage establishment of nematodes in the control lambs was 38%, 5717 nematodes recovered from 15,000 used to establish infection. In terms of species composition identified at post mortem the untreated control comprised 22% *Teladorsagia circumcincta*, 1% *Trichostrongylus axei*, 2% *Haemonchus contortus*, 24% *Trichostrongylus vitrinus* and 51% *Oesophagostomum venulosum* ([Fig. 2](#fig0010){ref-type="fig"}). Monepantel efficacies, when compared to the untreated control group, were 100%, 100%, 78%, 27% and 22% for *T. axei, H. contortus, T. circumcincta, T. vitrinus,* and *O. venulosum* respectively.Fig. 2Box-plot of estimated worm burden counts of untreated control (CON) lambs relative to monepantel treated (MPTL) lambs 7 days post treatment. Te. cir = *Teladorsagia circumcincta*; T. axe = *Trichostrongylus axei*; H. con = *Haemonchus contortus*; O. ven = *Oesophagostomum venulosum*; Total = total worm burden. Box = 25^th^ and 75^th^ percentiles with whiskers = maximum and minimum values, ⊕ = mean and ● = median.Fig. 2

4. Discussion {#sec0045}
=============

This study findings demonstrated that treatment with the manufacturer's recommended dose rate of 2.5 mg/kg bodyweight of monepantel was highly effective against *H. contortus* and *T. axei* (100%), albeit that only small numbers of adults of these species were detected in the untreated control lambs, but that three parasite species, *T. circumcincta, T. vitrinus* and *O. venulosum* were expressing resistance. The outcome confirms previous unproven suspicions that more than one resistant genus was present post monepantel administration on this farm ([@bib0040]).

Historically the first reports of resistance to broad-spectrum anthelmintic drugs have often been monogeneric in nature ([@bib0030]), generally involving *H. contortus* ([@bib0090]) or *T. circumcincta* ([@bib0035]) although cases of multigeneric resistance are not unprecedented. Initial reports of monepantel resistance globally have implicated a number of parasite genera, namely *T. circumcincta* ([@bib0085]), *T. colubriformis* ([@bib0085]), *H. contortus* ([@bib0070], [@bib0095]) and *Oesophagostomum* species ([@bib0015]).

The finding of multigeneric resistance may reflect the dynamic and diverse nature of nematode populations within livestock, complex animal movements within and between farms, and the widespread use of anthelmintic drugs for helminth control. So how might resistance in multiple species arise in a very short timeframe? Two routes of multigeneric resistance development have been proposed. Firstly, changes in nematode epidemiology and disease patterns influenced by farming practices, anthelmintic resistance and/or climate change ([@bib0100]) may allow anthelmintic drug exposure of some species at times and frequencies previously unseen. Secondly, due to the mobile nature of animals, and as a result of imperfect quarantine treatment strategies adopted by many farmers ([@bib0020]), it is possible that resistance by the different parasite species has been selected independently and transferred through animal movements. In the absence of contradictory evidence, our findings highlight the need for strict quarantine treatments for all new and returning stock and to ensure that the anthelmintic drug combinations used are fully effective through post quarantine drench efficacy tests.

The parasite make-up of the resistant population is interesting given the previous reports of monepantel resistance globally, where all of the species, barring *T. vitrinus*, have been implicated. Within the UK, surveys of resistance to other classes of anthelmintic have commonly identified *T. circumcincta* ([@bib0005]); occasionally identified *Trichostrongylus* ([@bib0005]), but rarely *Oesophagostomum*. *Oesophagostomum venulosum* was identified as one of the dose limiting species for monepantel with variable results (efficacy ranging between 86.8 and 96.5%) between the different trials conducted by Novartis AH ([@bib0045]). Although equivocal results have previously been reported against *Oesophagostomum* it is unlikely that the lack of efficacy observed in this study is solely the result of an innate insensitivity to the compound, but these findings merit further investigation.

The findings of this current study need to be kept in perspective, although multigeneric resistance was identified and reduces future treatment options on the index farm, this is currently an isolated case. Further study would be required to assess the scale of the problem in UK flocks. Nevertheless, the results highlight the importance of maintaining the awareness of producers to the possibility of anthelmintic resistant nematodes in sheep and the need to follow appropriate guidelines when it comes to quarantine treatment of new and returning stock and the merit of testing the efficacy of treatments on a regular basis to ensure that they are effective.
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